Catherine Skari
-
Sep- 2020 -9 September
-
8 SeptemberDelegation Visits 2020
Virtual Delegation Visit to France – 7 September 2020
A virtual TIF Delegation visit with stakeholders from France took place on 7 September 2020, with the Delegation Team consisting…
Read More » -
7 SeptemberNews
Thalassemics India News Update
The latest news from TIF’s Member ”Thalassemics India” in one place! In this issue you will find all the information…
Read More » -
7 SeptemberEducation
eThalED COURSE: Blood Transfusion in Thalassaemia by Dr. Farrukh Shah
TIF´s 4th Webinar for Medical Specialists and Healthcare Professionals, organised as part of our eThalED Course, was successfully held on…
Read More » -
5 September
-
2 SeptemberNews
AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine
AstraZeneca Plc has begun final-stage, Phase III trial of its coronavirus vaccine AZD1222 in the U.S., according to the company´s…
Read More » -
1 SeptemberNews
IMPORTANT ANNOUNCEMENT: TIF’s Renzo Galanello Fellowship Programme 2020 To Be Rescheduled and Compressed
Due to some difficulties and restrictions encountered as a result of the COVID-19 pandemic, the Renzo Galanello Fellowship Programme 2020 will…
Read More » -
Aug- 2020 -28 AugustNews
TIF Has Joined the EASL Patient Organisations Community
TIF is constantly fortifying synergies with influential patient organisations for the benefit of individuals with thalassaemia and other Haemoglobin Disorders. Therefore, we are…
Read More » -
27 AugustClinical News
Pfizer Has Reached Over 50% Enrollment for Coronavirus Vaccine Candidate Phase 3 Trial
One of the leading COVID-19 vaccine candidates currently in development is getting closer to a potential finish line. Pfizer said on Wednesday…
Read More » -
26 AugustMember News
Malaysian Health Minister: The Country Needs More Geneticists to Detect Thalassaemia Early
Malaysia needs more geneticists in order to identify thalassaemia patients at an early stage, stated Health Minister Datuk Seri Dr…
Read More »


